American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 257.e1-257.e14 , August 2007

Genetic Testing for X-Linked Alport Syndrome by Direct Sequencing of COL4A5 cDNA From Hair Root RNA Samples

  • Bárbara Tazón-Vega, PhD

      Affiliations

    • Molecular Biology Laboratory, Fundació Puigvert, Barcelona, Spain
    • ,
  • Elisabet Ars, PhD

      Affiliations

    • Molecular Biology Laboratory, Fundació Puigvert, Barcelona, Spain
    • ,
  • Moisès Burset, PhD

      Affiliations

    • Molecular Biology Laboratory, Fundació Puigvert, Barcelona, Spain
    • ,
  • Sheila Santín, BS

      Affiliations

    • Molecular Biology Laboratory, Fundació Puigvert, Barcelona, Spain
    • ,
  • Patricia Ruíz

      Affiliations

    • Molecular Biology Laboratory, Fundació Puigvert, Barcelona, Spain
    • ,
  • Patricia Fernández-Llama, MD, PhD

      Affiliations

    • Nephrology Department, Fundació Puigvert, Barcelona, Spain.
    • ,
  • José Ballarín, MD, PhD

      Affiliations

    • Nephrology Department, Fundació Puigvert, Barcelona, Spain.
    • ,
  • Roser Torra, MD, PhD

      Affiliations

    • Nephrology Department, Fundació Puigvert, Barcelona, Spain.
    • Corresponding Author InformationAddress correspondence to Roser Torra, MD, PhD, Hereditary Kidney Diseases, Nephrology Department, Fundació Puigvert, Cartagena 340-350, 08025 Barcelona, Spain.

Received 14 November 2006 ,Accepted 11 May 2007.

References 

  1. Pirson Y. Making the diagnosis of Alport’s syndrome. Kidney Int. 1999;56:760–775
  2. Kashtan CE. Alport syndromes: Phenotypic heterogeneity of progressive hereditary nephritis. Pediatr Nephrol. 2000;14:502–512
  3. Barker DF, Fain PR, Goldgar DE, et al. High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: Definition and use of flanking polymorphic markers. Hum Genet. 1991;88:189–194
  4. Barker DF, Atkin CL, Gregory MC, Fain PR. Application of linked markers for genetic diagnosis of Alport syndrome. Contrib Nephrol. 1996;117:29–45
  5. Turco AE, Bresin E, Rossetti S, et al. Rapid DNA-based prenatal diagnosis by genetic linkage in three families with Alport’s syndrome. Am J Kidney Dis. 1997;30:174–179
  6. Jais JP, Knebelmann B, Giatras I, et al. X-Linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol. 2000;11:649–657
  7. Pescucci C, Longo I, Bruttini M, Mari F, Renieri A. Type-IV collagen related diseases. J Nephrol. 2003;16:314–316
  8. King K, Flinter FA, Green PM. Hair roots as the ideal source of mRNA for genetic testing. J Med Genet. 2001;38:E20
  9. King K, Flinter FA, Nihalani V, Green PM. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome. Hum Genet. 2002;111:548–554
  10. King K, Flinter FA, Green PM. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome. Hum Mutat. 2006;27:1061
  11. Wang F, Wang Y, Ding J, Yang J. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int. 2005;67:1268–1274
  12. Gregory MC, Terreros DA, Barker DF, et al. Alport syndrome—Clinical phenotypes, incidence, and pathology. Contrib Nephrol. 1996;117:1–28
  13. Renieri A, Bruttini M, Galli L, et al. X-Linked Alport syndrome: An SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet. 1996;58:1192–1204
  14. Knebelmann B, Breillat C, Forestier L, et al. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet. 1996;59:1221–1232
  15. Inoue Y, Nishio H, Shirakawa T, et al. Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport’s syndrome by RT-PCR and direct sequencing. Am J Kidney Dis. 1999;34:854–862
  16. Ars E, Serra E, Garcia J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet. 2000;9:237–247
  17. Strachan T, Read AP. Human Molecular Genetics. New York, NY: Wiley; 1999;
  18. Kawai S, Nomura S, Harano T, et al. The COL4A5 gene in Japanese Alport syndrome patients: Spectrum of mutations of all exons (The Japanese Alport Network). Kidney Int. 1996;49:814–822
  19. Barker DF, Denison JC, Atkin CL, Gregory MC. Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP. Am J Med Genet. 2001;98:148–160
  20. Hertz JM, Juncker I, Persson U, et al. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome. Hum Mutat. 2001;18:141–148
  21. Plant KE, Green PM, Vetrie D, Flinter FA. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat. 1999;13:124–132
  22. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: Impact on clinical counselling. Nephrol Dial Transplant. 2002;17:1218–1227
  23. Pan X, Yan J, Ren H, et al. Detection of COL4A5 gene mutations in Chinese patients with Alport’s syndrome. Nephrol Dial Transplant. 2004;19:1123–1128
  24. Martin P, Heiskari N, Zhou J, et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol. 1998;9:2291–2301
  25. Lambrecht R, Gross O, Netzer KO, Seibold S, Weber M. Intergenic region between the collagen genes COL4A5 and COL4A6 is probably not affected in Alport syndrome: A study with 110 families. J Am Soc Nephrol. 1995;6:723A;(abstr)
  26. Arrondel C, Deschenes G, Le Meur Y, et al. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia. Kidney Int. 2004;65:2030–2040
  27. Wang YY, Rana K, Tonna S, et al. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney Int. 2004;65:786–790
  28. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A. 2003;100:189–192
  29. Guo C, Van Damme B, Damme-Lombaerts R, et al. Differential splicing of COL4A5 mRNA in kidney and white blood cells: A complex mutation in the COL4A5 gene of an Alport patient deletes the NC1 domain. Kidney Int. 1993;44:1316–1321
  30. Martin PH, Tryggvason K. Two novel alternatively spliced 9-bp exons in the COL4A5 gene. Pediatr Nephrol. 2001;16:41–44
  31. Ars E, Serra E, de la LS, Estivill X, Lazaro C. Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. Nucleic Acids Res. 2000;28:1307–1312
  32. Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet. 2001;27:55–58
  33. Eng L, Coutinho G, Nahas S, et al. Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene: Maximum entropy estimates of splice junction strengths. Hum Mutat. 2004;23:67–76
  34. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155–7174
  35. Ars E, Tazon-Vega B, Ruiz P, et al. Male-to-male transmission of X-linked Alport syndrome in a boy with a 47,XXY karyotype. Eur J Hum Genet. 2005;13:1040–1046
  36. Knebelmann B, Deschenes G, Gros F, et al. Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: Characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet. 1992;51:135–142
  37. Palenzuela L, Callis L, Vilalta R, et al. A new point mutation in the COL4A5 gene described in a Spanish family with X-linked Alport syndrome. Nephron. 2002;90:455–459
  38. Lemmink HH, Schroder CH, Brunner HG, et al. Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics. 1993;17:485–489
  39. Zhou J, Gregory MC, Hertz JM, et al. Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport syndrome. Kidney Int. 1993;43:722–729

 Originally published online as doi:10.1053/j.ajkd.2007.05.004 on July 10, 2007.

PII: S0272-6386(07)00825-6

doi: 10.1053/j.ajkd.2007.05.004

American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 257.e1-257.e14 , August 2007

Article Tools

* Image Usage & Resolution